73 related articles for article (PubMed ID: 9037954)
1. Screening and epidemiological trends in cervical cancer.
Kim SJ
J Obstet Gynaecol Res; 1996 Dec; 22(6):621-7. PubMed ID: 9037954
[TBL] [Abstract][Full Text] [Related]
2. Comparison of single-, double- and triple-combined testing, including Pap test, HPV DNA test and cervicography, as screening methods for the detection of uterine cervical cancer.
Kim JH; Kim IW; Kim YW; Park DC; Kim YW; Lee KH; Ahn TG; Han SJ; Ahn WS
Oncol Rep; 2013 Apr; 29(4):1645-51. PubMed ID: 23443346
[TBL] [Abstract][Full Text] [Related]
3. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
4. Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness.
van Ballegooijen M; van den Akker-van Marle ME; Warmerdam PG; Meijer CJ; Walboomers JM; Habbema JD
Br J Cancer; 1997; 76(5):651-7. PubMed ID: 9303366
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer.
Walboomers JM; de Roda Husman AM; Snijders PJ; Stel HV; Risse EK; Helmerhorst TJ; Voorhorst FJ; Meijer CJ
J Clin Pathol; 1995 Aug; 48(8):728-32. PubMed ID: 7560199
[TBL] [Abstract][Full Text] [Related]
6. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
Othman N; Othman NH
Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
[TBL] [Abstract][Full Text] [Related]
7. [Integrating HPV testing for primary screening?].
Riethmuller D; Ramanah R; Pretet JL; Mougin C
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S139-51. PubMed ID: 18191912
[TBL] [Abstract][Full Text] [Related]
8. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus.
Goldie SJ; Freedberg KA; Weinstein MC; Wright TC; Kuntz KM
Am J Med; 2001 Aug; 111(2):140-9. PubMed ID: 11498068
[TBL] [Abstract][Full Text] [Related]
10. [Relation of cervical cancer with the results of human papillomavirus (HPV) screening carried out via hybrid capture 2 method on 52.000 women in Erzurum].
Göktuğ Kadıoğlu B; Çınar Tanrıverdi E; Alay H; Uçar M
Mikrobiyol Bul; 2018 Oct; 52(4):367-375. PubMed ID: 30522422
[TBL] [Abstract][Full Text] [Related]
11. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus screening and cervical cancer prevention.
Sasieni PD
J Am Med Womens Assoc (1972); 2000; 55(4):216-9. PubMed ID: 10935355
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear.
Blumenthal PD; Gaffikin L; Chirenje ZM; McGrath J; Womack S; Shah K
Int J Gynaecol Obstet; 2001 Jan; 72(1):47-53. PubMed ID: 11146077
[TBL] [Abstract][Full Text] [Related]
14. Can self vaginal douching for high risk HPV screening replace or assist efficacy of cervical cancer screening?
Suwannarurk K; Bhamarapravatana K; Kheolamai P; Thaweekul Y; Mairaing K; Poomtavorn Y; Pattaraarchachai J
Asian Pac J Cancer Prev; 2010; 11(5):1397-401. PubMed ID: 21198300
[TBL] [Abstract][Full Text] [Related]
15. Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention.
Moreira ED; Oliveira BG; Ferraz FM; Costa S; Costa Filho JO; Karic G
Int J Gynecol Cancer; 2006; 16(2):599-603. PubMed ID: 16681732
[TBL] [Abstract][Full Text] [Related]
16. Screening. The next century.
Richart RM
Cancer; 1995 Nov; 76(10 Suppl):1919-27. PubMed ID: 8634983
[TBL] [Abstract][Full Text] [Related]
17. Comparative Study of Cytology and Histopathology of Cervical Lesion in VIA Positive Patients and Its Correlation with High Risk Human Papilloma Virus.
Ansari NP; Saleh FM; Shahida SM; Rahman EN
Mymensingh Med J; 2017 Jul; 26(3):505-513. PubMed ID: 28919602
[TBL] [Abstract][Full Text] [Related]
18. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening.
Lörincz AT
J Obstet Gynaecol Res; 1996 Dec; 22(6):629-36. PubMed ID: 9037955
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination.
Chen MK; Hung HF; Duffy S; Yen AM; Chen HH
J Eval Clin Pract; 2011 Dec; 17(6):1050-8. PubMed ID: 21679279
[TBL] [Abstract][Full Text] [Related]
20. Screening for cervical cancer in Latin America: a case-control study.
Herrero R; Brinton LA; Reeves WC; Brenes MM; de Britton RC; Gaitan E; Tenorio F
Int J Epidemiol; 1992 Dec; 21(6):1050-6. PubMed ID: 1336485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
